PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
August 7, 2024Blood AdvancesOpen Access

Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database

View Full Paper
Ask AI
Bookmark
Share

Authors

BDBinod DhakalHEHermann EinseleJSJordan M. Schecter

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dhakal et al. (2024) studied this question.

synapsesocial.com/papers/68e5d23bb6db6435875680ffhttps://doi.org/10.1182/bloodadvances.2024012640
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma2022 · 251 citations
  2. 2Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 12011 · 1,042 citations
  3. 3Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma2021 · 32 citations